To assess the efficacy and safety of pharmacological and electrical cardioversion for atrial fibrillation (AF).
This is a protocol.
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis
You may also be interested in:
- Implantable cardioverter defibrillators versus medical therapy for people with inherited heart rhythm abnormalities
- Drugs and pacemakers for transient loss of consciousness
- Compared to single chamber ventricular pacemakers, dual chamber pacemakers may reduce the incidence of complications in people with sick sinus syndrome and atrioventricular block
- Implantable cardiac monitors compared with conventional methods for the detection of atrial high-rate episodes in individuals with embolic stroke of undetermined source
- Clinical service organisation for adults with atrial fibrillation
Health topics: